SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-19-002296
Filing Date
2019-01-22
Accepted
2019-01-22 17:00:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 TO SCHEDULE 13D tv511274_sc13da.htm SC 13D/A 49866
  Complete submission text file 0001144204-19-002296.txt   51364
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filed by) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Subject) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87630 | Film No.: 19535864
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences